Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2010 1
2011 1
2012 1
2013 1
2016 1
2019 1
2021 2
2022 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.
Hyams JS, Turner D, Cohen SA, Szakos E, Kowalska-Duplaga K, Ruemmele F, Croft NM, Korczowski B, Lawrence P, Bhatia S, Kadali H, Chen C, Sun W, Rosario M, Kabilan S, Treem W, Rossiter G, Lirio RA. Hyams JS, et al. Among authors: szakos e. J Crohns Colitis. 2022 Aug 30;16(8):1243-1254. doi: 10.1093/ecco-jcc/jjac036. J Crohns Colitis. 2022. PMID: 35301512 Free PMC article. Clinical Trial.
Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease.
Müller KE, Lakatos PL, Kovacs JB, Arato A, Varkonyi A, Nemes E, Tarnok A, Toth G, Papp M, Solyom E, Horvath A, Guthy I, Kovacs M, Veres G; Hungarian Pediatric IBD Registry Group. Müller KE, et al. J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):50-5. doi: 10.1097/MPG.0000000000000885. J Pediatr Gastroenterol Nutr. 2016. PMID: 26192700
Adherence to the Porto Criteria Based on the Hungarian Nationwide Pediatric Inflammatory Bowel Disease Registry (HUPIR).
Müller KE, Dezsőfi A, Cseh Á, Szűcs D, Vass N, Nemes É, Kadenczki O, Tárnok A, Szakos E, Guthy I, Kovács M, Karoliny A, Czelecz J, Tokodi I, Tomsits E, Veres G. Müller KE, et al. Among authors: szakos e. Front Pediatr. 2021 Sep 3;9:710631. doi: 10.3389/fped.2021.710631. eCollection 2021. Front Pediatr. 2021. PMID: 34631616 Free PMC article.
Guselkumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients: results of the phase 3, randomized, placebo-controlled PROTOSTAR study.
Prajapati VH, Seyger MMB, Wilsmann-Theis D, Szakos E, Kaszuba A, van Hartingsveldt B, Jett M, Jiang G, Li S, Sinha V, Crauwels H, DeKlotz CMC, Paller AS. Prajapati VH, et al. Among authors: szakos e. Br J Dermatol. 2024 Dec 21:ljae502. doi: 10.1093/bjd/ljae502. Online ahead of print. Br J Dermatol. 2024. PMID: 39708367
Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE, Lakatos PL, Arató A, Kovács JB, Várkonyi Á, Szűcs D, Szakos E, Sólyom E, Kovács M, Polgár M, Nemes É, Guthy I, Tokodi I, Tóth G, Horváth Á, Tárnok A, Csoszánszki N, Balogh M, Vass N, Bódi P, Dezsőfi A, Gárdos L, Micskey E, Papp M, Cseh Á, Szabó D, Vörös P, Veres G; Hungarian IBD Registry Group (HUPIR). Müller KE, et al. Among authors: szakos e. J Pediatr Gastroenterol Nutr. 2013 Nov;57(5):576-82. doi: 10.1097/MPG.0b013e31829f7d8c. J Pediatr Gastroenterol Nutr. 2013. PMID: 23820399
[Analysis of infliximab treated pediatric patients with Crohn disease in Hungary].
Veres G, Szabó D, Várkonyi A, Tari B, Polgár M, B Kovács J, Horváth A, Tomsits E, Tokodi I, Bodánszky H, Dezsofi A, Szakos E, Vass N, Ruszinkó V, Kovács M, Müller KE, Arató A. Veres G, et al. Among authors: szakos e. Orv Hetil. 2010 Jan 31;151(5):179-83. doi: 10.1556/OH.2010.28792. Orv Hetil. 2010. PMID: 20083466 Clinical Trial. Hungarian.
13 results